Sign in to view content

Diabetic Retinopathy Progression in Anti-VEGF versus Fluocinolone Acetonide Implant Treated Eyes Who are Lost to Follow-up

Caesar K. Luo, MD, FASRS

Video
Published 2020

Related

BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Updates from the Field
2019
Short-term Oral Mifepristone for the Treatment of Central Serous Chorioretinopathy (STOMP-CSC): A Placebo-Controlled Clinical Trial
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2018
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of DR Worsening Over Time: Results of DRCR Retina Network Protocol AA
Dennis M. Marcus, MD
Annual Meeting Talks
2022

Category: Diabetic Retinopathy

See more